SIFI is a manufacturing and pharmaceutical company that has been committed to improving patients’ quality of vision since 1935. Based in Italy, the company has recently made strides in expanding into the international market by providing innovative solutions for ocular diseases. The last investment in SIFI was a Private Equity Round on 21 April 2015, with 21 Centrale Partners as the investors. This strategic move not only reflects the company's dedication to making a global impact but also indicates its appeal to reputable backers in the investment community. With a rich history in the industry and a recent injection of private equity funding, SIFI positions itself as a potential player to watch in the international pharmaceutical and manufacturing sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 1 |
|
21 Apr 2015 |
We care about your data, and we'd love to use cookies make your experience better.
